C 83 H 82 N4O5, monoclinic, P21/c (no. 14), a = 21.705(8) Å, b = 18.455(6) Å, c = 17.774(7) Å, β = 112.216(6)°, V = 6591(4) Å 3 , Z = 4, Rgt(F) = 0.0647, wR ref (F 2 ) = 0.1531, T = 128 K.
Rigaku [1] , Olex2 [2] , SHELX [3, 4] UV-light in methanol/THF solution. After approximately one week. By thin-layer chromatography, the residue was purified using ethyl acetate-petroleum ether (1:5 v/v). After concentration in vacuo colorless solids were collected and dried, and recrystallized from acetone. After one week colorless crystals of the title compound were obtained.
Experimental details
The diazatetrakishomocubanes hydrogen atom as well as those at acetone were refined freely. Fixed U iso at 1.2 times were set for all C(H) groups, and 1.5 times for all C(H,H,H) groups. The hydrogen atoms attached to carbon were [2] .
Comment
The structural similarity of the C 2 -symmetric tetrakishomocubanes compound to the 3,9-diazatetraasteranes gives rises to great interest in these compounds in particular as potential inhibitors of C 2 -symmetric HIV-1 protease [5] . X-ray crystallography analyses reveal that the title compound contains 3,12-diazatetrakishomocubanes. The asymmetric unit -containing two diazatetrakishomocubanes (systematic name: dimethyl 1,9-dibenzyl-4,6-diphenylhexahydro-3H -2,7,3,5-(epimethanetriyliminomethanetriyl)cyclopenta[b]pyridine-3,7(2H)-dicarboxylate) and one acetone molecule -of the title structure is shown in the figure. Crystal structure analysis revealed that the piperidinyl rings are in chair conformation, the apexes (prows) being the N2 and C3 atoms. In contrast to the previously observed head-to-tail 1,4-dihydropyridine dimers with centrosymmetric cage structures of 3,9-diazatetraasteranes or their C 2 -symmetric, syn-dimeric intermediates, the linkage of the two 1,4-dihydropyridine rings in the compound is not in a head-to-tail arrangement of 180°to each other, but form an angle of only 90°. Stereochemically the compound is the product of common enantiometric forms. It can formally be considered as resulting from the attack of one dihydropyridine molecule on the far side of the dihydropyridine ring of the second molecule (i.e., the side that does not face the aryl moiety). Steric reasons are responsible for the axial arrangement of the phenyl rings in this case [5] .
Because of the Csp 2 nature of the substituent at C3, the orientation of the cyclohexyl ring around the C3-C15 bond is characterized by the following torsion angles: C2-C3-C15-C16: −8.5°, C4-C3-C15-C16: −129.57°. On the other hand, the torsion angle N1-C27-C28-C29 is 50.4°.
The geometric parameters of the second crystallographically independent molecule are very similar to the one discuss before.
